Registered number
10927371
(England & Wales)
Arza Bioscience Limited
Filleted Accounts
29 February 2024
Arza Bioscience Limited
Registered number: 10927371
Balance Sheet
as at 29 February 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 3 406 6,242
Current assets
Stocks 980 980
Debtors 4 223,124 78,937
Cash at bank and in hand 82,852 209,454
306,956 289,371
Creditors: amounts falling due within one year 5 (195,950) (179,674)
Net current assets 111,006 109,697
Total assets less current liabilities 111,412 115,939
Creditors: amounts falling due after more than one year 6 (16,797) (25,154)
Net assets 94,615 90,785
Capital and reserves
Called up share capital 100 100
Profit and loss account 94,515 90,685
Shareholders' funds 94,615 90,785
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Hamna Ismailjee
Director
Approved by the board on 27 November 2024
Arza Bioscience Limited
Notes to the Accounts
for the year ended 29 February 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildings over 50 years
Leasehold land and buildings over the lease term
Plant and machinery over 5 years
Fixtures, fittings, tools and equipment over 5 years
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 0 0
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 March 2023 37,919
At 29 February 2024 37,919
Depreciation
At 1 March 2023 31,677
Charge for the year 5,836
At 29 February 2024 37,513
Net book value
At 29 February 2024 406
At 28 February 2023 6,242
4 Debtors 2024 2023
£ £
Trade debtors 11,900 13,584
Other debtors 211,224 65,353
223,124 78,937
5 Creditors: amounts falling due within one year 2024 2023
£ £
Bank loans and overdrafts 10,648 10,648
Trade creditors 1,139 23,718
Taxation and social security costs 2,332 7,988
Accruals and deferred income 181,831 137,320
195,950 179,674
6 Creditors: amounts falling due after one year 2024 2023
£ £
Bank loans 16,797 25,154
7 Related party transactions
Included in other debtors, interest free advances were made to the directors during the year. These were repayable on demand.

Total advances and credits in the year: £79,288

Amount Repaid: £79,288
8 Controlling party
The controlling interest is held by the director Mrs Hamna Ismailjee who owns 90% of the issued and alloted share capital of the company.
9 Other information
Arza Bioscience Limited is a private company limited by shares and incorporated in England. Its registered office is:
32 Westland Avenue
Bolton
Lancashire
BL1 5NP
Arza Bioscience Limited 10927371 false 2023-03-01 2024-02-29 2024-02-29 VT Final Accounts July 2024 Hamna Ismailjee No description of principal activity 10927371 2022-03-01 2023-02-28 10927371 core:WithinOneYear 2023-02-28 10927371 core:AfterOneYear 2023-02-28 10927371 core:ShareCapital 2023-02-28 10927371 core:RetainedEarningsAccumulatedLosses 2023-02-28 10927371 2023-03-01 2024-02-29 10927371 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 10927371 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 10927371 bus:Director40 2023-03-01 2024-02-29 10927371 1 2023-03-01 2024-02-29 10927371 2 2023-03-01 2024-02-29 10927371 core:PlantMachinery 2023-03-01 2024-02-29 10927371 countries:England 2023-03-01 2024-02-29 10927371 bus:FRS102 2023-03-01 2024-02-29 10927371 bus:FilletedAccounts 2023-03-01 2024-02-29 10927371 2024-02-29 10927371 core:WithinOneYear 2024-02-29 10927371 core:AfterOneYear 2024-02-29 10927371 core:ShareCapital 2024-02-29 10927371 core:RetainedEarningsAccumulatedLosses 2024-02-29 10927371 core:PlantMachinery 2024-02-29 10927371 2023-02-28 10927371 core:PlantMachinery 2023-02-28 iso4217:GBP xbrli:pure